TY - JOUR
T1 - Urticaria
AU - Vigand Svendsen, Sebastian
AU - Griffiths Ettrup Lange, Natascha
AU - Christensen, Morten Junker
AU - Gotthard Mørtz, Charlotte
AU - Bindslev-Jensen, Carsten
PY - 2024/4/15
Y1 - 2024/4/15
N2 - Urticaria is a frequent skin condition presenting with wheals, angioedema or both due to the activation of mast cells. Acute urticaria (< 6 weeks duration) is associated with infections and allergies, whereas chronic urticaria (≥ 6 weeks) is either spontaneous (chronic spontaneous urticaria (CSU)), inducible or both. Quality of life (QoL) is frequently impaired. The pathogenesis of CSU is often of an autoimmune nature. As argued in this review, the treatment aims to restore QoL with a stepwise approach, most often using second-generation H1-antihistamines, omalizumab and cyclosporine.
AB - Urticaria is a frequent skin condition presenting with wheals, angioedema or both due to the activation of mast cells. Acute urticaria (< 6 weeks duration) is associated with infections and allergies, whereas chronic urticaria (≥ 6 weeks) is either spontaneous (chronic spontaneous urticaria (CSU)), inducible or both. Quality of life (QoL) is frequently impaired. The pathogenesis of CSU is often of an autoimmune nature. As argued in this review, the treatment aims to restore QoL with a stepwise approach, most often using second-generation H1-antihistamines, omalizumab and cyclosporine.
KW - Humans
KW - Quality of Life
KW - Histamine H1 Antagonists
KW - Chronic Disease
KW - Urticaria/drug therapy
KW - Angioedema
M3 - Tidsskriftartikel
C2 - 38078471
SN - 0041-5782
VL - 186
JO - Ugeskrift for Læger
JF - Ugeskrift for Læger
IS - 8
M1 - V04230240
ER -